Pioneering Non-Invasive Solutions for Neurological Disease Management
Blinkcns utilizes the blink reflex using its FDA-cleared EyeStat device - a 30-second, non-invasive test that delivers faster, objective data for neurological assessment and disease management, empowering earlier detection, personalized care, and improved patient care and outcomes.
A Game-Changer in Neurology
The first FDA-cleared technology indicated to measure and assess the blink reflex.
EyeStat5
Blinkcns expanded its technology and can now be used both in a clinical and telehealth (e.g., athletic facility or in-home) setting. Our i-blink app for clinicians and patients is available on iPhone and Android mobile devices. This innovation enables low-cost and objective capturing of spontaneous and stimulated blinking for enhanced neurological management.
How It Works
Eyestat 5 – Patient Assessment
STEP 1
Insert mobile device into EyeStat5 with the camera lens facing inward and oriented toward the top
STEP 2
Mobile device will insert to the point where its camera lens is centered within the EyeStat5
STEP 3
Launch EyeStat5 software and confirm the patient’s eyes are centered on mobile device screen
STEP 4
Press the record button to initiate the scan
- Non-invasive
- 30 Second test
- 7,200 High-resolution pictures of the eye
STEP 5
The post scan screen provides options to review, save, delete or rescan
Rapid Results
Using a proprietary algorithm, 100 parameters of the blink reflex are measured. A comprehensive medical record is generated for review by a clinician.
7,200 Frames
High-resolution cameras record the blink reflex at 240 frames/sec, capturing 7,200 objective data points in 30 seconds.
Cloud Storage
Results and data are transferred and stored in the encrypted Cloud Portal for access and analysis at any time.
30-Sec Test
Over 30 seconds, eight light puffs of air are delivered to the corner of the eye, stimulating the blink reflex.
Under 3lbs
A portable and battery-operated device, EyeStat can be operated anywhere with ease.
Areas of Research
Our Clinical and Research Partners
Researcher Reviews
Discover how our neurological disease technology is revolutionizing the medical and research fields.
Blinking assessment is relevant in understanding the nervous system function and dysfunction.
Blinkcns' technology has emerged as an innovative tool in this field, providing swift, objective, and reliable measurements of blinking for research and clinical purposes. In the latter regard, by offering such precise assessments, Blinkcns' technology has the potential to significantly aid in evaluating various neurological and psychiatric disorders characterized by both overt and/or subtle blinking changes.
Blinkcns's technology has proven to obtain fast, objective, and quantitative metrics of a human blink reflex that will fill the gap existing for centuries in the medical evaluation of disorder having clinical and subclinical blink reflex alterations.
Through the expedient measure of the blink reflex, the technology produced by BlinkCNS shows tremendous promise in achieving this high standards for concussion management as well as other neurological disorders.
.png)
Stay in the Loop
Keep abreast of the latest trends and breakthroughs in neurological science through our news articles, upcoming events,and press releases.
Blinkcns Strengthens its Advisory Board with the Appointment of Civic Entrepreneur and Women in Leadership Advocate Sylvie Légère
Blinkcns, Inc, a biotech company pioneering blink reflex technology intended to improve the detection and management of neurological disease and conditions, is thrilled to announce the addition of Sylvie Légère to its advisory board. A social entrepreneur, investor, philanthropist, and co-founder of The Policy Circle,
Read More
